{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T12:23:36Z","timestamp":1791548616095,"version":"4.3.4"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,5,3]],"date-time":"2022-05-03T00:00:00Z","timestamp":1651536000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,5,3]],"date-time":"2022-05-03T00:00:00Z","timestamp":1651536000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"tasly biopharmaceuticals co., ltd"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl. Stroke Res."],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s12975-022-01012-9","type":"journal-article","created":{"date-parts":[[2022,5,3]],"date-time":"2022-05-03T19:18:13Z","timestamp":1651605493000},"page":"995-1004","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Efficacy and Safety of Recombinant Human Prourokinase in Acute Ischemic Stroke: A Phase IIa Randomized Clinical Trial"],"prefix":"10.1007","volume":"13","author":[{"given":"Haiqing","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingfeng","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huisheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianguo","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongqiu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runxiu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liandong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qilin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongzhong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyang","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weidong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongbo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yansong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wuwei","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xunming","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6482-9710","authenticated-orcid":false,"given":"Yuping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,3]]},"reference":[{"key":"1012_CR1","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1136\/svn-2017-000112","volume":"3","author":"X Wang","year":"2018","unstructured":"Wang X, You S, Sato S, Yang J, Carcel C, Zheng D, Yoshimura S, Anderson CS, Sandset EC, Robinson T, et al. Current status of intravenous tissue plasminogen activator dosage for acute ischaemic stroke: An updated systematic review. Stroke Vasc Neurol. 2018;3:28\u201333. https:\/\/doi.org\/10.1136\/svn-2017-000112.","journal-title":"Stroke Vasc Neurol."},{"key":"1012_CR2","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.ejphar.2017.11.026","volume":"818","author":"CH Hao","year":"2018","unstructured":"Hao CH, Ding WX, Sun Q, Li XX, Wang WT, Zhao ZY, Tang LD. Effect of human recombinant prourokinase(rhpro-uk) on thromboembolic stroke in rats. Eur J Pharmacol. 2018;818:429\u201334. https:\/\/doi.org\/10.1016\/j.ejphar.2017.11.026.","journal-title":"Eur J Pharmacol."},{"key":"1012_CR3","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3892\/br.2017.1013","volume":"8","author":"C Hao","year":"2018","unstructured":"Hao C, Ding W, Xu X, Sun Q, Li X, Wang W, Zhao Z, Tang L. Effect of recombinant human prourokinase on thrombolysis in a rabbit model of thromboembolic stroke. Biomed Rep. 2018;8:77\u201384. https:\/\/doi.org\/10.3892\/br.2017.1013.","journal-title":"Biomed Rep."},{"key":"1012_CR4","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1212\/wnl.50.4.870","volume":"50","author":"K Takano","year":"1998","unstructured":"Takano K, Carano RA, Tatlisumak T, Meiler M, Sotak CH, Kleinert HD, Fisher M. Efficacy of intra-arterial and intravenous prourokinase in an embolic stroke model evaluated by diffusion-perfusion magnetic resonance imaging. Neurology. 1998;50:870\u20135. https:\/\/doi.org\/10.1212\/wnl.50.4.870.","journal-title":"Neurology"},{"key":"1012_CR5","first-page":"26","volume":"42","author":"Prourokinase Clinical Trial Group","year":"2013","unstructured":"Prourokinase Clinical Trial Group. Multicenter phase III study of recombinant prourokinase for acute myocardial infarction with ST-segment evaluation. J Med Res. 2013;42:26\u201331 ((In Chinese)).","journal-title":"J Med Res"},{"key":"1012_CR6","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1161\/01.str.29.1.4","volume":"29","author":"GJ del Zoppo","year":"1998","unstructured":"del Zoppo GJ, Higashida RT, Furlan AJ, Pessin MS, Rowley HA, Gent M. Proact: A phase ii randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Proact investigators. Prolyse in acute cerebral thromboembolism. Stroke. 1998;29:4\u201311. https:\/\/doi.org\/10.1161\/01.str.29.1.4.","journal-title":"Stroke"},{"key":"1012_CR7","doi-asserted-by":"publisher","first-page":"e46","DOI":"10.1161\/STR.0000000000000158","volume":"49","author":"WJ Powers","year":"2018","unstructured":"Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, Biller J, Brown M, Demaerschalk BM, Hoh B, et al. 2018 guidelines for the early management of patients with acute ischemic stroke: A guideline for healthcare professionals from the american heart association\/american stroke association. Stroke. 2018;49:e46\u2013110. https:\/\/doi.org\/10.1161\/STR.0000000000000158.","journal-title":"Stroke"},{"key":"1012_CR8","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1056\/NEJMoa0804656","volume":"359","author":"W Hacke","year":"2008","unstructured":"Hacke W, Kaste M, Bluhmki E, Brozman M, Davalos A, Guidetti D, Larrue V, Lees KR, Medeghri Z, Machnig T, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008;359:1317\u201329. https:\/\/doi.org\/10.1056\/NEJMoa0804656.","journal-title":"N Engl J Med."},{"key":"1012_CR9","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1161\/STROKEAHA.115","volume":"46","author":"R von Kummer","year":"2015","unstructured":"von Kummer R, Broderick JP, Campbell BC, Demchuk A, Goyal M, Hill MD, Treurniet KM, Majoie CB, Marquering HA, Mazya MV, et al. The heidelberg bleeding classification: Classification of bleeding events after ischemic stroke and reperfusion therapy. Stroke. 2015;46:2981\u20136. https:\/\/doi.org\/10.1161\/STROKEAHA.115.","journal-title":"Stroke"},{"key":"1012_CR10","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1161\/01.res.0000014825.71092.bd","volume":"90","author":"JN Liu","year":"2002","unstructured":"Liu JN, Liu JX, Liu Bf BF, Sun Z, Zuo JL, Zhang Px PX, Zhang J, Chen Yh YH, Gurewich V. Prourokinase mutant that induces highly effective clot lysis without interfering with hemostasis. Circ Res. 2002;90:757\u201363. https:\/\/doi.org\/10.1161\/01.res.0000014825.71092.bd.","journal-title":"Circ Res."},{"key":"1012_CR11","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1002\/ana.410320113","volume":"32","author":"GJ del Zoppo","year":"1992","unstructured":"del Zoppo GJ, Poeck K, Pessin MS, Wolpert SM, Furlan AJ, Ferbert A, Alberts MJ, Zivin JA, Wechsler L, Busse O, et al. Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol. 1992;32:78\u201386. https:\/\/doi.org\/10.1002\/ana.410320113.","journal-title":"Ann Neurol"},{"key":"1012_CR12","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1001\/jama.282.21.2003","volume":"282","author":"A Furlan","year":"1999","unstructured":"Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Kase C, Pessin M, Ahuja A, Callahan F, Clark WM, et al. Intra-arterial prourokinase for acute ischemic stroke. The proact ii study: A randomized controlled trial. Prolyse in acute cerebral thromboembolism. JAMA. 1999;282:2003\u201311. https:\/\/doi.org\/10.1001\/jama.282.21.2003.","journal-title":"JAMA"},{"key":"1012_CR13","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1161\/STROKEAHA.119.025080","volume":"50","author":"AM Burgos","year":"2019","unstructured":"Burgos AM, Saver JL. Evidence that tenecteplase is noninferior to alteplase for acute ischemic stroke: Meta-analysis of 5 randomized trials. Stroke. 2019;50:2156\u201362. https:\/\/doi.org\/10.1161\/STROKEAHA.119.025080.","journal-title":"Stroke"},{"key":"1012_CR14","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1016\/S1474-4422(09)70264-9","volume":"8","author":"E Bluhmki","year":"2009","unstructured":"Bluhmki E, Chamorro A, Davalos A, Machnig T, Sauce C, Wahlgren N, Wardlaw J, Hacke W. Stroke treatment with alteplase given 3.0\u20134.5 h after onset of acute ischaemic stroke (ecass iii): Additional outcomes and subgroup analysis of a randomised controlled trial. Lancet Neurol. 2009;8:1095\u2013102. https:\/\/doi.org\/10.1016\/S1474-4422(09)70264-9.","journal-title":"Lancet Neurol"},{"key":"1012_CR15","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/S0140-6736(04)15692-4","volume":"363","author":"W Hacke","year":"2004","unstructured":"Hacke W, Donnan G, Fieschi C, Kaste M, von Kummer R, Broderick JP, Brott T, Frankel M, Grotta JC, Haley EC Jr, et al. Association of outcome with early stroke treatment: Pooled analysis of atlantis, ecass, and ninds rt-pa stroke trials. Lancet. 2004;363:768\u201374. https:\/\/doi.org\/10.1016\/S0140-6736(04)15692-4.","journal-title":"Lancet"},{"key":"1012_CR16","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1056\/NEJMoa1109842","volume":"366","author":"M Parsons","year":"2012","unstructured":"Parsons M, Spratt N, Bivard A, Campbell B, Chung K, Miteff F, O\u2019Brien B, Bladin C, McElduff P, Allen C, et al. A randomized trial of tenecteplase versus alteplase for acute ischemic stroke. N Engl J Med. 2012;366:1099\u2013107. https:\/\/doi.org\/10.1056\/NEJMoa1109842.","journal-title":"N Engl J Med."},{"key":"1012_CR17","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/S1474-4422(15)70017-7","volume":"14","author":"X Huang","year":"2015","unstructured":"Huang X, Cheripelli BK, Lloyd SM, Kalladka D, Moreton FC, Siddiqui A, Ford I, Muir KW. Alteplase versus tenecteplase for thrombolysis after ischaemic stroke (attest): A phase 2, randomised, open-label, blinded endpoint study. Lancet Neurol. 2015;14:368\u201376. https:\/\/doi.org\/10.1016\/S1474-4422(15)70017-7.","journal-title":"Lancet Neurol"},{"key":"1012_CR18","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/S1474-4422(17)30253-3","volume":"16","author":"N Logallo","year":"2017","unstructured":"Logallo N, Novotny V, Assmus J, Kvistad CE, Alteheld L, R\u00f8nning OM, Thommessen B, Amthor KF, Ihle-Hansen H, Kurz M, et al. Tenecteplase versus alteplase for management of acute ischaemic stroke (nor-test): A phase 3, randomised, open-label, blinded endpoint trial. Lancet Neurol. 2017;16:781\u20138. https:\/\/doi.org\/10.1016\/S1474-4422(17)30253-3.","journal-title":"Lancet Neurol"}],"container-title":["Translational Stroke Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12975-022-01012-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12975-022-01012-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12975-022-01012-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,28]],"date-time":"2022-10-28T04:16:27Z","timestamp":1666930587000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12975-022-01012-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,3]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1012"],"URL":"https:\/\/doi.org\/10.1007\/s12975-022-01012-9","relation":{},"ISSN":["1868-4483","1868-601X"],"issn-type":[{"value":"1868-4483","type":"print"},{"value":"1868-601X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,3]]},"assertion":[{"value":"6 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The clinical trial was accepted by the National Medical Products Administration (No. 2016L05323) and approved by the institutional review boards of the 23 participating centers. The study was conducted in accordance with the principles of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethic approval"}},{"value":"Written informed consent was obtained from all patients prior to enrollment.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Dr Liu R reports being an employee of Tasly Biopharmaceuticals Co.,Ltd,. No other potential conflict of interest relevant to this article was reported.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}